✦ LIBER ✦

Concomitant chemotherapy (CT) and radiotherapy (RT) in advanced squamous cell carcinoma of the head and neck (SCCHN): A pharmacokineticandclinical survey-up date

✍ Scribed by E. Lartigau; M. Degardin; A. Lansiaux; B. Coche-Dequeant; C. Fournier; J.L. Lefebvre

Book ID: 119518253
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 237 KB
Volume: 82
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(07)80147-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8570 POSTER Phase II Study of Cetuximab

8570 POSTER Phase II Study of Cetuximab With Concomitant-boost Radiotherapy (RT) in Japanese Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

✍ Fujii, M.; Yoshino, T.; Onozawa, Y.; Kodaira, T.; Ota, M.; Gross, A.; Tsukuda, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Chemotherapy and radiotherapy (CT+RT) vs

Chemotherapy and radiotherapy (CT+RT) vs. chemotherapy alone (CT) in the treatment of advanced head and neck cancer (HNC)

✍ L. Bergmann; A. Klima; A. Zoubek; S. Szepesi; C. v. Ilberg; P. S. Mitrou 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Pilot trial of concomitant chemotherapy

Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck

✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; João V. Salvajoli; Andrew J. Si 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

149 Neoadjuvant docetaxel/cisplatin/fluo

149 Neoadjuvant docetaxel/cisplatin/fluorouracill (TPF) before concurrent chemo-radiotherapy (CT-RT) versus concomitant CT-RT alone in locally advanced squamous cell carcinoma (SCC) of head and neck. A phase II feasibility study

✍ M.G. Ghi; A. Paccagnella; P. D'amanzo; C.A. Mione; S. Fasan; R. Carnuccio; C. Ma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 305 KB

438 M-VAC chemotherapy and GM-CSF in adv

438 M-VAC chemotherapy and GM-CSF in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

✍ M. Degardin; P. Cappelaere; A. Caty; J.L. Lefebvre 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 152 KB

148 Prognostic and predictive factors in

148 Prognostic and predictive factors in patients with advanced squamous cell head and neck cancer (HNSCC) treated with induction chemotherapy (CT) and radiotherapy (RT)

✍ A. Mucha-Malecka; S. Korzeniowski; J. Rys 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 147 KB